CUBT
Curative Biotechnology Inc
NYSE MKT: CUBT · HEALTHCARE · BIOTECHNOLOGY
$0.94
+0.00% today
Updated 2026-04-29
Market cap
$1.07B
P/E ratio
—
P/S ratio
158.53x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Curative Biotechnology Inc (CUBT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-3.98%
ROA
-0.64%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $128392.00 | $-913000.00 | -251.57% | -786.65% | -711.10% |
| 2011 | $159818.00 | $-492000.00 | 3.70% | -289.70% | -307.85% |
| 2012 | $133995.00 | $-306000.00 | -49.21% | -212.69% | -228.37% |
| 2013 | $323825.00 | $-63138.00 | 95.13% | -12.11% | -19.50% |
| 2014 | $132324.00 | $-77919.00 | 75.73% | -43.11% | -58.89% |
| 2015 | $113264.00 | $190836.00 | 75.98% | -76.94% | 168.49% |
| 2016 | $11091.00 | $-17400.00 | 96.33% | -13.69% | -156.88% |
| 2017 | $0.00 | $-22983.00 | — | — | — |
| 2018 | $0.00 | $-29914.00 | — | — | — |
| 2019 | $0.00 | $331953.00 | — | — | — |
| 2020 | $0.00 | $-4.67M | — | — | — |
| 2021 | $0.00 | $-5.34M | — | — | — |
| 2022 | $0.00 | $-5.38M | — | — | — |
| 2023 | — | $-3.96M | — | — | — |
| 2024 | — | $-3.56M | — | — | — |